Account
Poster
15.10.2025
Revisiting rarity: Would yesterday’s NICE highly...

Objectives:  ​​In March 2025, NICE adopted new HST routing criteria for evaluating technolo...

Read more
Webinar
08.10.2025
Navigating NICE’s HST Pathway: Insights from Bot...

NICE’s Highly Specialised Technologies (HST) Programme offers a vital route for bringing ultra-rar...

Read more
Guide
08.09.2025
NICE Summary Guide 2025: What the Appraisal Reform...

NICE has introduced important appraisal reforms for 2025 that will directly impact manufacturers pre...

Read more
Checklist
08.09.2025
NICE Submission Checklist: Your Guide to STA &...

Preparing a NICE submission can feel overwhelming. Whether it’s a Single Technology Appraisal (STA...

Read more
Articles
21.07.2025
From submission to guidance: Demystifying the NICE...

The vast majority of products launching in the UK will be assessed by the National Institute for Hea...

Read more
Articles
14.07.2025
Engaging Stakeholders: The Power of Patient and Cl...

Decisions regarding National Institute for Health and Care Excellence (NICE) appraisals are not made...

Read more
Articles
07.07.2025
NICE 2025 Update: How New Appraisal Reforms Impact...

The National Institute of Health and Care Excellence (NICE) has published several updates and releas...

Read more
Articles
30.06.2025
Avoiding pitfalls: Top 5 reasons NICE HST/STA subm...

Most pharmaceutical products hoping to launch in the UK will be assessed by NICE as a Single Technol...

Read more
Articles
25.06.2025
Mastering NICE submissions: The three pillars for ...

Securing a positive recommendation from the National Institute for Health and Care Excellence (NICE)...

Read more
Articles
16.06.2025
HST or STA? Navigating NICE’s Dual Pathways for ...

When bringing a new health technology to market in England, pharmaceutical and biotech companies mus...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.